Literature DB >> 15749184

Minor myocardial damage detected by troponin T is a powerful predictor of long-term prognosis in patients with acute decompensated heart failure.

Eduardo R Perna1, Stella M Macín, Juan P Cimbaro Canella, Pablo M Alvarenga, Nelson G Ríos, Rolando Pantich, Natalia Augier, Eduardo F Farías, Eloísa Jantus, Monica Brizuela, Fernanda Medina.   

Abstract

BACKGROUND: The progression of chronic heart failure (CHF) is characterized by frequent exacerbation requiring hospitalization and high mortality. Clinical deterioration is triggered by many factors that could promote ongoing myocytes injury. We sought to determine whether a specific marker of cardiac injury, troponin T (cTnT), is associated with prognosis in acute decompensated heart failure (ADHF).
METHODS: One hundred and eighty-four consecutive patients with ADHF were enrolled in the absence of an acute coronary syndrome. A cTnT value> or =0.1 ng/ml in samples drawn at 6, 12 or 24 h after hospital admission was considered abnormal.
RESULTS: Increased levels of cTnT were found in 58 patients (31.5%, group 1). There were no significant differences between group 1 and patients with cTnT<0.1 ng/ml (group 2) in terms of demographic and clinical characteristics, although ischemic etiology was more prevalent in group 1 (51.7% vs. 31.7%, p=0.009). During follow-up, the mortality in groups 1 and 2 was 31% and 17.5% (p=0.038, OR=2.13, 95% CI: 1.03-4.69), respectively. The 3-year free-CHF readmission survival in group 1 and 2 was 25% and 53% (log rank test p=0.015). In a Cox proportional hazard model, poor tissue perfusion (HR=2.46, 95% CI=1.31-4.6), previous infarction (HR=1.99, 95% CI=1.02-3.9) and cTnT> or =0.1 ng/ml (HR=1.74, 95% CI=1.05-2.9) emerged as the independent predictors of long-term outcome.
CONCLUSIONS: One third of patients with decompensated CHF had elevated levels of cTnT. Troponin T was an independent long-term prognostic marker of morbidity and mortality and it suggests a role of biochemical risk stratification in this setting.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15749184     DOI: 10.1016/j.ijcard.2004.01.017

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  18 in total

1.  Troponin T levels in patients with acute heart failure: clinical and prognostic significance of their detection and release during hospitalisation.

Authors:  Marco Metra; Luca Bettari; Franca Pagani; Valentina Lazzarini; Carlo Lombardi; Valentina Carubelli; Graziella Bonetti; Silvia Bugatti; Giovanni Parrinello; Luigi Caimi; G Michael Felker; Livio Dei Cas
Journal:  Clin Res Cardiol       Date:  2012-03-10       Impact factor: 5.460

2.  National Academy of Clinical Biochemistry (NACB) laboratory medicine guidelines on the clinical utilization and analytical issues for cardiac biomarker testing in heart failure.

Authors:  John Beilby
Journal:  Clin Biochem Rev       Date:  2008-08

Review 3.  Prognostic factors in patients hospitalized for heart failure.

Authors:  Lakshmi Sridharan; Liviu Klein
Journal:  Curr Heart Fail Rep       Date:  2013-12

4.  Role of Cardiac Troponin Levels in Acute Heart Failure.

Authors:  Nicholas Wettersten; Alan Maisel
Journal:  Card Fail Rev       Date:  2015-10

5.  Prognostic significance of a multimarker strategy of biomarkers in acute heart failure.

Authors:  P Srinivas; C N Manjunath; Shaheena Banu; K S Ravindranath
Journal:  J Clin Diagn Res       Date:  2014-09-20

Review 6.  Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure : a clinical review.

Authors:  David R Buvat de Virginy
Journal:  Heart Fail Rev       Date:  2006-12       Impact factor: 4.214

7.  Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study.

Authors:  Ali Ahmed; Richard M Allman; Gregg C Fonarow; Thomas E Love; Faiez Zannad; Louis J Dell'italia; Michel White; Mihai Gheorghiade
Journal:  J Card Fail       Date:  2008-04       Impact factor: 5.712

8.  Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial.

Authors:  Robert J Mentz; Bradley D Allen; Mary J Kwasny; Marvin A Konstam; James E Udelson; Andrew P Ambrosy; Angela J Fought; Muthiah Vaduganathan; Christopher M O'Connor; Faiez Zannad; Aldo P Maggioni; Karl Swedberg; Robert O Bonow; Mihai Gheorghiade
Journal:  Eur J Heart Fail       Date:  2012-09-11       Impact factor: 15.534

9.  Cationic isotachophoresis separation of the biomarker cardiac troponin I from a high-abundance contaminant, serum albumin.

Authors:  Thomas Jacroux; Danny Bottenus; Bennett Rieck; Cornelius F Ivory; Wen-Ji Dong
Journal:  Electrophoresis       Date:  2014-06-05       Impact factor: 3.535

10.  Profile of patients with acute heart failure and elevated troponin I levels.

Authors:  Jana Sukova; Petr Ostadal; Petr Widimsky
Journal:  Exp Clin Cardiol       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.